做全球创新药械的首发“福地”,上海为企业提供哪些加速包

第一财经
Oct 16, 2025

获批创新药械数量是衡量生物医药科技和产业创新水平的“金标准”。2025上海国际生物医药产业周期间举行的成果展数据显示,2021至2025年9月,上海获批上市国产1类创新药合计30个;获批上市境内第三类创新医疗器械数量达45个,在药械创新竞争中领跑全国。而上海对于生物医药产业接下来的规划,是全力推动“基础研究、孵化转化、临床试验、审评审批、落地生产、推广应用”全链条加速,建设世界级生物医药创新高地和...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10